FDA Approved: LIOTHYRONINE SODIUM — Original Application (Biocon Pharma Inc.)

View source ↗

Summary

FDA approved Liothyronine sodium (Biocon Pharma Inc.) under an Original Application (ANDA) as a generic treatment for hypothyroidism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypothyroidism

Drugs mentioned

• Liothyronine Sodium (Liothyronine Sodium)

Snippet

ORIG AP for LIOTHYRONINE SODIUM (LIOTHYRONINE SODIUM)